Why it matters:
The article highlights the increasing trend of over-the-counter (OTC) drug overdose in Japan, particularly among young women. It also mentions the potential legalization of medical cannabis in the country.
What they are saying:
Data from the National Center of Neurology and Psychiatry reveals a sixfold increase in addiction cases involving OTC drugs between 2012 and 2020. A more recent study by Saitama Medical University’s Clinical Toxicology Center found that 124 patients were hospitalized for OTC drug overdosing between May 2021 and December 2022. The majority of patients were young women in their 20s or younger, with suicide or self-harm as the main motive for overdose.
The big picture:
The findings suggest that young people, even those integrated into society, have worries they can’t share and find it difficult to cope. They turn to OTC drugs as a means of escape, especially in the absence of traditional support systems like friends and school due to the COVID-19 pandemic. The strict prohibition on drugs in Japan may also contribute to the popularity of OTC drug misuse.
What to watch:
It will be important to monitor the impact of the COVID-19 pandemic on mental health in Japan and its relation to OTC drug overdose. Legalizing medical cannabis may offer an alternative treatment option for individuals struggling with mental health issues.
My take:
The increasing number of OTC drug overdose cases among young women in Japan is concerning. It highlights the need for improved mental health support and awareness within society, including both home and school environments. Legalizing medical cannabis could offer potential benefits in managing mental health conditions, but it should be implemented with proper regulation and education to avoid further drug misuse.
